TY  - GEN
AU  - Schneeweiss-Gleixner,Mathias
AU  - Byrgazov,Konstantin
AU  - Stefanzl,Gabriele
AU  - Berger,Daniela
AU  - Eisenwort,Gregor
AU  - Lucini,Chantal Blanche
AU  - Herndlhofer,Susanne
AU  - Preuner,Sandra
AU  - Obrova,Klara
AU  - Pusic,Petra
AU  - Witzeneder,Nadine
AU  - Greiner,Georg
AU  - Hoermann,Gregor
AU  - Sperr,Wolfgang R
AU  - Lion,Thomas
AU  - Deininger,Michael
AU  - Valent,Peter
AU  - Gleixner,Karoline V
TI  - CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1
SN  - 2352-3964
PY  - 2020///0430
KW  - Adult
KW  - Aged
KW  - Apoptosis
KW  - drug effects
KW  - Cell Cycle
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cyclin-Dependent Kinase 4
KW  - antagonists & inhibitors
KW  - Cyclin-Dependent Kinase 6
KW  - Dose-Response Relationship, Drug
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Drug Synergism
KW  - Female
KW  - Fusion Proteins, bcr-abl
KW  - Humans
KW  - Hydroxyurea
KW  - pharmacology
KW  - Imidazoles
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Protein Kinase Inhibitors
KW  - Pyridazines
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.ebiom.2019.11.004
ER  -